These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 23651519)

  • 1. SUMO-1 conjugation blocks beta-amyloid-induced astrocyte reactivity.
    Hoppe JB; Rattray M; Tu H; Salbego CG; Cimarosti H
    Neurosci Lett; 2013 Jun; 546():51-6. PubMed ID: 23651519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. P38K and JNK pathways are induced by amyloid-β in astrocyte: Implication of MAPK pathways in astrogliosis in Alzheimer's disease.
    Saha P; Guha S; Biswas SC
    Mol Cell Neurosci; 2020 Oct; 108():103551. PubMed ID: 32896578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of synaptic plasticity and cognition by SUMO in normal physiology and Alzheimer's disease.
    Lee L; Dale E; Staniszewski A; Zhang H; Saeed F; Sakurai M; Fa' M; Orozco I; Michelassi F; Akpan N; Lehrer H; Arancio O
    Sci Rep; 2014 Dec; 4():7190. PubMed ID: 25448527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of inducible nitric oxide synthase expression by sumoylation.
    Akar CA; Feinstein DL
    J Neuroinflammation; 2009 Mar; 6():12. PubMed ID: 19323834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pivotal role of SUMO-1-JNK-Tau axis in an in vitro model of oxidative stress counteracted by the protective effect of curcumin.
    Buccarello L; Dragotto J; Iorio F; Hassanzadeh K; Corbo M; Feligioni M
    Biochem Pharmacol; 2020 Aug; 178():114066. PubMed ID: 32502496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alteration of global protein SUMOylation in neurons and astrocytes in response to Alzheimer's disease-associated insults.
    Maruyama T; Wada H; Abe Y; Niikura T
    Biochem Biophys Res Commun; 2018 Jun; 500(2):470-475. PubMed ID: 29660340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of Abeta generation by small ubiquitin-like modifiers does not require conjugation to target proteins.
    Dorval V; Mazzella MJ; Mathews PM; Hay RT; Fraser PE
    Biochem J; 2007 Jun; 404(2):309-16. PubMed ID: 17346237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SUMO and Alzheimer's disease.
    Lee L; Sakurai M; Matsuzaki S; Arancio O; Fraser P
    Neuromolecular Med; 2013 Dec; 15(4):720-36. PubMed ID: 23979993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. E2-mediated small ubiquitin-like modifier (SUMO) modification of thymine DNA glycosylase is efficient but not selective for the enzyme-product complex.
    Coey CT; Fitzgerald ME; Maiti A; Reiter KH; Guzzo CM; Matunis MJ; Drohat AC
    J Biol Chem; 2014 May; 289(22):15810-9. PubMed ID: 24753249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Profiles of SUMO and ubiquitin conjugation in an Alzheimer's disease model.
    McMillan LE; Brown JT; Henley JM; Cimarosti H
    Neurosci Lett; 2011 Sep; 502(3):201-8. PubMed ID: 21843595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small ubiquitin-like modifier (SUMO) conjugation impedes transcriptional silencing by the polycomb group repressor Sex Comb on Midleg.
    Smith M; Mallin DR; Simon JA; Courey AJ
    J Biol Chem; 2011 Apr; 286(13):11391-400. PubMed ID: 21278366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endocytosis and Transcytosis of Amyloid-β Peptides by Astrocytes: A Possible Mechanism for Amyloid-β Clearance in Alzheimer's Disease.
    Domínguez-Prieto M; Velasco A; Tabernero A; Medina JM
    J Alzheimers Dis; 2018; 65(4):1109-1124. PubMed ID: 30103329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small ubiquitin-like modifier 1-3 conjugation [corrected] is activated in human astrocytic brain tumors and is required for glioblastoma cell survival.
    Yang W; Wang L; Roehn G; Pearlstein RD; Ali-Osman F; Pan H; Goldbrunner R; Krantz M; Harms C; Paschen W
    Cancer Sci; 2013 Jan; 104(1):70-7. PubMed ID: 23078246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Positive and negative regulation of APP amyloidogenesis by sumoylation.
    Li Y; Wang H; Wang S; Quon D; Liu YW; Cordell B
    Proc Natl Acad Sci U S A; 2003 Jan; 100(1):259-64. PubMed ID: 12506199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amyloid-beta peptide activates cultured astrocytes: morphological alterations, cytokine induction and nitric oxide release.
    Hu J; Akama KT; Krafft GA; Chromy BA; Van Eldik LJ
    Brain Res; 1998 Mar; 785(2):195-206. PubMed ID: 9518610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Mdm-2 amino terminus is required for Mdm2 binding and SUMO-1 conjugation by the E2 SUMO-1 conjugating enzyme Ubc9.
    Buschmann T; Lerner D; Lee CG; Ronai Z
    J Biol Chem; 2001 Nov; 276(44):40389-95. PubMed ID: 11384992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Potential involvement of abnormal increased SUMO-1 in modulation of the formation of Alzheimer's disease senile plaques and neuritic dystrophy in APP/PS1 transgenic mice].
    Zhao XY; Wang DD; Shan Y; Zhu CQ
    Sheng Li Xue Bao; 2013 Jun; 65(3):253-62. PubMed ID: 23788181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ca
    Silveirinha VC; Lin H; Tanifuji S; Mochida S; Cottrell GS; Cimarosti H; Stephens GJ
    Cell Calcium; 2021 Jan; 93():102326. PubMed ID: 33360835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Site-specific inhibition of the small ubiquitin-like modifier (SUMO)-conjugating enzyme Ubc9 selectively impairs SUMO chain formation.
    Wiechmann S; Gärtner A; Kniss A; Stengl A; Behrends C; Rogov VV; Rodriguez MS; Dötsch V; Müller S; Ernst A
    J Biol Chem; 2017 Sep; 292(37):15340-15351. PubMed ID: 28784659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta-amyloid-induced changes in cultured astrocytes parallel reactive astrocytosis associated with senile plaques in Alzheimer's disease.
    Pike CJ; Cummings BJ; Monzavi R; Cotman CW
    Neuroscience; 1994 Nov; 63(2):517-31. PubMed ID: 7891862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.